Cassava Sciences Mourns the Death of Board Member Sanford “Sandy” Robertson
Rhea-AI Summary
Cassava Sciences, Inc. (Nasdaq: SAVA) has announced the passing of long-time board member Sanford "Sandy" Robertson. Robertson had served on the company's Board of Directors since its inception as a public company in 1998. The press release highlights Robertson's significant contributions to Cassava Sciences and his impact on the business world, noting his role in helping build hundreds of companies and supporting entrepreneurs. The announcement emphasizes Robertson's commitment to Cassava's mission, his business acumen, and his personal qualities of intelligence and kindness. While the news does not directly impact the company's operations or financials, it marks the loss of a key figure in Cassava Sciences' leadership history.
Positive
- None.
Negative
- None.
News Market Reaction – SAVA
On the day this news was published, SAVA gained 20.51%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
AUSTIN, Texas, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA) today reflected on the passing of long-time board member Sanford Robertson.
We are profoundly saddened by the passing of our dear friend and colleague, Sandy Robertson. Sandy served on the Board of Directors of Cassava Sciences since its inception as a public company in 1998. Sandy's commitment to Cassava’s mission and success was unwavering. Sandy’s success in the business world is well recognized by the hundreds of companies that he helped build and the entrepreneurs who created those companies. Everyone who knew or worked alongside Sandy understood his powerful intelligence as well as his remarkable kindness. His success in business was legendary but what those who knew him will remember was who he was: Sandy was the personification of someone who would treat others as he would like to be treated. We will miss him terribly as will anyone who knew him.
About Cassava Sciences, Inc.
Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. For more information, please visit: https://www.CassavaSciences.com
For More Information Contact:
Eric Schoen, Chief Financial Officer
(512) 501-2450, or eschoen@CassavaSciences.com